Phase II Evaluation of Sorafenib in Advanced and Metastatic Squamous Cell Carcinoma of the Head and Neck: Southwest Oncology Group Study S0420 von WILLIAMSON, Stephen K, MOON, James, HUANG, Chao H, GUAGLIANONE, Perry P, LEBLANC, Michael, WOLF, Gregory T, URBA, Susan G

Volltext

A Phase I-II Evaluation of Veliparib (NSC #737664), Topotecan, and Filgrastim or Pegfilgrastim in the Treatment of Persistent or Recurrent Carcinoma of the Uterine Cervix: An NRG O... von Kunos, Charles, Deng, Wei, Dawson, Dawn, Lea, Jayanthi S., Zanotti, Kristine M., Gray, Heidi J., Bender, David P., Guaglianone, Perry P., Carter, Jori S., Moore, Kathleen N.

Volltext

Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327) von Lara, Primo N., Chansky, Kari, Davies, Angela M., Franklin, Wilbur A., Gumerlock, Paul H., Guaglianone, Perry P., Atkins, James N., Farneth, Nichole, Mack, Philip C., Crowley, John J., Gandara, David R.

Volltext

Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327) von Lara, Primo N., Chansky, Kari, Davies, Angela M., Franklin, Wilbur A., Gumerlock, Paul H., Guaglianone, Perry P., Atkins, James N., Farneth, Nichole, Mack, Philip C., Crowley, John J., Gandara, David R.

Volltext

Synthesis and characterization of biotin-labeled nucleotide analogs von Shimkus, M L, Guaglianone, P, Herman, T M

Volltext